Application Information

This drug has been submitted to the FDA under the reference 204819/001.

Names and composition

"ADEMPAS" is the commercial name of a drug composed of RIOCIGUAT.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
204819/001 ADEMPAS RIOCIGUAT TABLET/ORAL 0.5MG
204819/002 ADEMPAS RIOCIGUAT TABLET/ORAL 1MG
204819/003 ADEMPAS RIOCIGUAT TABLET/ORAL 1.5MG
204819/004 ADEMPAS RIOCIGUAT TABLET/ORAL 2MG
204819/005 ADEMPAS RIOCIGUAT TABLET/ORAL 2.5MG

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
204819/001 ADEMPAS RIOCIGUAT TABLET/ORAL 0.5MG
204819/002 ADEMPAS RIOCIGUAT TABLET/ORAL 1MG
204819/003 ADEMPAS RIOCIGUAT TABLET/ORAL 1.5MG
204819/004 ADEMPAS RIOCIGUAT TABLET/ORAL 2MG
204819/005 ADEMPAS RIOCIGUAT TABLET/ORAL 2.5MG

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved